Earnings Outlook For Eagle Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Eagle Pharmaceuticals (NASDAQ:EGRX) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $1.05. The company's past performance shows a trend of share price drops following earnings beats. The stock is currently trading at $21.53, down 40.68% over the last 52-week period.
August 07, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Eagle Pharmaceuticals is expected to report an EPS of $1.05 in its upcoming earnings. The company's stock has historically dropped following earnings beats, and is currently down 40.68% over the last 52 weeks.
The company's stock has shown a trend of dropping following earnings beats, which could indicate investor skepticism about the company's ability to sustain its performance. Additionally, the stock's negative return over the past year could further dampen investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100